Skip to main content
. 2012 May 25;206(3):309–318. doi: 10.1093/infdis/jis371

Table 3.

Characteristics of Study 3: Prospective Validation Group

Characteristic Retinopathy Positive (n = 71) Retinopathy Negative (n = 30) P Value
Gender, % male 47.8 50 1.00
Age in months 45.3 ± 25.3 51.7 ± 25.3 .25
Temperature on admission, °C 38.8 ± 1.3 39.0 ± 1.1 .40
Blantyre Coma Score on admission 1.3 ± 0.6 1.3 ± 0.6 .78
History of convulsions, % positive 85.7 93.5 .33
History of hypoglycemia,a % positive 36.6 33.3 .66
Laboratory values on admission
 Parasitemia, per μLb 60 621 28 280 .20
 Hematocrit 19.5 ± 5.3 29.3 ± 6.5 <.001
 Lactate, mmol/L 7.7 ± 4.9 6.0 ± 3.7 .09
 pHRP-2, ng/μL 6668 ± 5041 810 ± 916 <.001
 Platelets, per μL 71 809 ± 61 558 171 923 ± 107 125 <.001
 WBCs, per μL 13 415 ± 10 519 13 712 ± 9 481 .90
 HIV positive, % 7.5 16.7 .24
Fever clearance time in hours 44.2 ± 49.7 44.8 ± 37.1 .96
Coma resolution time in hours 49.5 ± 37.7 32.1 ± 22.7 .04
Parasite clearance time in hours 42.8 ± 14.2 37.9 ± 14.3 .13
Mortality rate, % 14.3 19.4 .56

Abbreviations: HIV, human immunodeficiency virus; pHRP2, parasite histidine-rich protein 2; WBCs, white blood cells.

a Whole blood glucose concentration ≤2.2 mmoL/L.

b Geometric mean.